Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1994 | |
| Gross Profit | 3,690 | 3,600 | 1,782 |
| Operating Expenses | 1,690 | 1,730 | 3,825 |
| Operating Income | -1,690 | -1,730 | -3,825 |
| Pre-tax Income | -1,690 | -1,730 | -3,825 |
| Net Income Continuous | -1,690 | -1,730 | -3,825 |
| Net Income | $-1,690 | $-1,730 | $-3,825 |
| EBITDA(a) | $-1,200 | $-1,180 | $-3,672 |